Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) was the recipient of a significant decrease in short interest in August. As of August 31st, there was short interest totaling 3,087 shares, a decrease of 82.3% from the August 15th total of 17,431 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average trading volume of 24,723 shares, the short-interest ratio is currently 0.1 days.
Raia Drogasil Price Performance
Shares of OTCMKTS RADLY traded down $0.08 during mid-day trading on Friday, hitting $3.73. The company had a trading volume of 6,891 shares, compared to its average volume of 32,766. The stock’s 50-day moving average price is $3.67 and its 200-day moving average price is $4.01. Raia Drogasil has a 1 year low of $3.08 and a 1 year high of $5.34.
Raia Drogasil (OTCMKTS:RADLY – Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.05. Raia Drogasil had a return on equity of 18.20% and a net margin of 2.97%.The company had revenue of $2.17 billion for the quarter, compared to the consensus estimate of $2.32 billion. Equities research analysts anticipate that Raia Drogasil will post 0.17 earnings per share for the current year.
Raia Drogasil Company Profile
Raia Drogasil, now operating under the brand name RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a nationwide network of pharmacies that sells prescription and over-the-counter medicines, personal-care products, cosmetics, health and wellness items, and convenience products.
The company also provides digital shopping and delivery services through its online channels, supporting customers with medication and health-related purchases. Its operations combine physical stores with e-commerce and other healthcare-related services, serving consumers throughout Brazil.
RD Saúde was formed in 2011 through the merger of Drogasil and Droga Raia, two pharmacy chains with roots dating back to the early twentieth century.
See Also
- Five stocks we like better than Raia Drogasil
- Optical Cable Corporation Is Starting to Get the Market’s Attention
- Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
- Is Nike’s Index Demotion a Warning or a Buying Opportunity?
- American Eagle Goes on Sale: Is It Time to Buy?
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
